Complex Dosing, Polypharmacy Common With Interstitial Lung Disease

THURSDAY, March 14, 2019 -- Polypharmacy and complex medication regimens are common in patients with interstitial lung disease (ILD), according to a study published online Feb. 20 in Respirology. Yet H. Khor, M.B.B.S., Ph.D., from the University of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news